Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Healthtrust
Boehringer Ingelheim
Novartis
Deloitte
Express Scripts
US Army
Queensland Health
QuintilesIMS

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,428,709

« Back to Dashboard

Which drugs does patent 8,428,709 protect, and when does it expire?

Patent 8,428,709 protects IONSYS and is included in one NDA.

This patent has seventy-four patent family members in eighteen countries.
Summary for Patent: 8,428,709
Title:Current control for electrotransport drug delivery
Abstract: Devices, systems and methods for controlling the application of current and/or voltage to deliver drug from patient contacts of an electrotransport drug delivery device by indirectly controlling and/or monitoring the applied current without directly measuring from the cathode of the patient terminal. In particular, described herein are electrotransport drug delivery systems including constant current delivery systems having a feedback current and/or voltage control module that is isolated from the patient contacts (e.g., anodes and cathodes). The feedback module may be isolated by a transistor from the patient contacts; feedback current and/or voltage control measurements may be performed at the transistor rather than at the patient contact (e.g., cathode).
Inventor(s): White; Bradley E. (Mason, OH), Hayter; Paul (Mountain View, CA), Lemke; John (Pleasanton, CA), Satre; Scot (Brentwood, CA), Chen; Corinna X. (Oakland, CA), Read; Brian W. (Brier, WA), Dougherty; Jason E. (Seattle, WA)
Assignee: Incline Therapeutics, Inc. (Redwood City, CA) Alza Corporation (Vacaville, CA)
Application Number:13/493,314
Patent Claim Types:
see list of patent claims
Delivery; Use;

Drugs Protected by US Patent 8,428,709

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
The Medicines Co IONSYS fentanyl hydrochloride SYSTEM;IONTOPHORESIS, TRANSDERMAL 021338-001 May 22, 2006 RX Yes Yes ➤ Subscribe ➤ Subscribe Y METHOD FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF FENTANYL HYDROCHLORIDE ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,428,709

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,364,656 Method of storing an electrotransport drug delivery device ➤ Subscribe
8,301,238 Two-part electrotransport device ➤ Subscribe
8,428,708 Self-test for analgesic product ➤ Subscribe
9,645,179 Self-test for analgesic product ➤ Subscribe
9,095,706 Self-test for analgesic product ➤ Subscribe
8,781,571 Switch validation circuit and method ➤ Subscribe
9,731,121 Switch validation circuit and method ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,428,709

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Russian Federation 2014153102 ➤ Subscribe
Russian Federation 2629242 ➤ Subscribe
Russian Federation 2014151720 ➤ Subscribe
Russian Federation 2564084 ➤ Subscribe
Russian Federation 2013148572 ➤ Subscribe
Russian Federation 2557690 ➤ Subscribe
Russian Federation 2013148574 ➤ Subscribe
Portugal 2858715 ➤ Subscribe
Portugal 2691148 ➤ Subscribe
New Zealand 702360 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
QuintilesIMS
Moodys
Medtronic
Accenture
AstraZeneca
McKesson
Johnson and Johnson
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot